quaternary amine linker antibody-drug conjugates (Seattle Genetics)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namequaternary amine linker antibody-drug conjugates (Seattle Genetics)
Drug Alias NameDAR8-alphaCD30-mDPR-val-cit-PABD-AEDAR8-aphaCD30-mDPR-glucQ-Tub
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHodgkin Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSeagen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSeagen Inc
Active IndicationsN/A
Inactive IndicationsHodgkin Disease

Other Information

ATC CodeN/A
Related LinksN/A